Author:
Tasić-Kostov Marija,Ilić Dušan
Publisher
Centre for Evaluation in Education and Science (CEON/CEES)
Reference31 articles.
1. França K, Litewka S. Controversies in off-label prescriptions in dermatology: the perspective of the patient, the physician, and the pharmaceutical companies. Int J Dermatol 2019; 58(7):788-94. https://onlinelibrary.wiley.com/doi/10.1111/ijd.14222;
2. Savić M. Lekovi za dermatološku primenu - klasifikacija i mehanizmi dejstva. Arhiv za farmaciju, 2013; 63(2): 116-28. https://scindeks.ceon.rs/article.aspxquery=ISSID%26and%2610965&page=1&sort=8&stype=0&backurl=%2fissue.aspx%3fissue%3d10965;
3. Kelidari HR, Saeedi M, Akbari J, et al. Formulation optimization and in vitro skin penetration of spironolactone loaded solid lipid nanoparticles. Colloids Surf B 2015; 128: 473-9. https://www.ncbi.nlm.nih.gov/pubmed/25797482;
4. Sugarman J, Fleischer A, Feldman S. Off-label prescribing in the treatment of dermatologic disease. J Am Acad Dermatol 2002; 47: 217-23. https://www.sciencedirect.com/science/article/pii/ S0190962202000506?via%3Dihub;
5. Hsien-Yi C, Tsen-Fang T. Topical use of systemic drugs in dermatology: A comprehensive review. J Am Acad Dermatol 2011; 65(5): 1048.e1-1048.e22. https://www.jaad.org/article/S0190-9622(10)01052-2/abstract;
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献